Calibrating Type I Error Under the Null

Why Calibrate Type I Error?

A trial analysis may use a nominal significance level such as \(\alpha=0.05\), but that number does not by itself guarantee a 5% false-positive rate in the trial being planned. The guarantee depends on the assumptions and details of the analysis: the outcome distribution, allocation, missing-data process, nuisance parameters, multiplicity rules, and the way estimation or convergence failures are handled. Simulation makes it possible to evaluate the actual planned decision procedure under data-generating scenarios where the treatment effect is null.

The goal is not simply to count small p-values from a convenient null model. It is to estimate the rejection probability across relevant null scenarios, identify conditions where it exceeds the intended error rate, and, if needed, adjust the decision rule. The earlier material on operating characteristics and simulation replicates provides the basic framework; here the focus is false-positive control.

In a simulation, each replicate produces a dataset and the planned analysis produces a decision. Define \(Z_r=1\) if replicate \(r\) meets the prespecified criterion for rejecting \(H_0\), and \(Z_r=0\) otherwise. For \(M\) independent replicates at one null setting, the estimated rejection probability is \(\hat q=\sum_{r=1}^{M}Z_r/M\). This is an estimate of the false-positive rate at that setting, not proof that the method controls error across every possible null value.

Specify the Null Scenarios and the Decision Rule

A null scenario must state which treatment effect is null and what values are used for the other parameters. Under a composite null, the treatment effect may be zero while nuisance parameters vary. Depending on the endpoint and design, relevant nuisance parameters can include residual variance, baseline event risk, covariate distribution, correlation, dropout, adherence, or the amount of between-participant variability. The scenario grid should vary parameters that could plausibly alter either the data or the operating behavior of the analysis.

For every scenario, keep the decision rule identical to the one intended for the trial. It may include more than a nominal p-value cut-off: for example, a multiplicity adjustment, a gatekeeping sequence, a minimum data requirement, or a specified rule for analysis failures. If a simulated analysis fails, decide in advance how that outcome maps to the trial decision. Silently removing failed replicates changes the quantity being estimated and can distort the false-positive rate. Report failure frequency separately, and apply the prespecified decision policy consistently.

When the null is composite, report scenario-specific rates rather than pooling all scenarios automatically. A weighted average answers a different question: it is the error probability under a particular distribution over scenarios. It does not establish control at each scenario. If the intended claim is control throughout a range, simulation can evaluate selected points in that range, but a finite grid alone cannot establish a mathematical guarantee at every untested point.

Monte Carlo Uncertainty and a Short Derivation

The estimated rate is itself random because it is based on a finite number of replicates. At a fixed scenario, if replicates are generated independently and the decision rule is applied consistently, each \(Z_r\) is Bernoulli with rejection probability \(q\). Thus \(E(Z_r)=q\), \(\operatorname{Var}(Z_r)=q(1-q)\), and \(\hat q\) is the mean of \(M\) independent indicators. Its variance and estimated standard error are:

The standard error describes Monte Carlo uncertainty in estimating the rejection probability at the specified scenario. It does not measure uncertainty about whether the simulated data-generating model is realistic. With enough replicates, Monte Carlo uncertainty can be made small, but that alone cannot repair an inappropriate scenario or an incorrect implementation.

When the replicate count is large and the estimated rate is not near zero or one, an approximate 95% interval is \(\hat q\pm1.96SE(\hat q)\). This is a useful measure of simulation precision, not a probability statement that the fixed true rate lies in this particular interval. If the estimate is near a boundary or the replicate count is modest, use a binomial interval designed for those conditions rather than relying on the normal approximation.

Vary Nuisance Parameters, Not Just the Treatment Effect

A null simulation with one convenient nuisance-parameter setting can miss important problems. For example, a test’s behavior may change when group sizes are unequal and outcome variances differ. Baseline event risk can affect the performance of an analysis for a binary endpoint. Dropout and informative missingness can alter the observed data available to the planned model. Which factors matter depends on the design, endpoint, data-generating process, and analysis.

Include plausible combinations that challenge the analysis without changing the null hypothesis of interest. Keep a clear record of each scenario’s defining values. If the study uses parameter uncertainty, distinguish a conditional rate at a fixed parameter setting from an average rate over sampled parameters. The average can summarize performance under a specified parameter distribution, but it can conceal a high error rate in a particular region.

Use the Actual Threshold and Full Decision Process

A simulation is informative only if “reject” means what it will mean in the trial. If the protocol declares success when either of two endpoints meets its threshold, count a rejection whenever either endpoint satisfies that rule. If success requires both endpoints to meet their thresholds, use that conjunction instead. Simulating each endpoint separately and reporting its marginal rate does not, by itself, give the false-positive rate for the overall claim.

The same principle applies to interim analyses, subgroups, and multiple comparisons: implement the complete prespecified decision process, including its actual thresholds and any adjustment. A threshold that is correct for one test may not control the probability of at least one false positive across several opportunities to claim success. Where a rule is complex, encode it explicitly, test it with known cases, and verify that the simulation’s rejection indicator matches the written rule.

Diagnostics, Calibration, and Limitations

Before interpreting an apparent inflation or deflation, check that the null was truly generated, the analysis matches the planned method, the rejection direction and threshold are implemented correctly, and every replicate is accounted for. Inspect the distribution of key simulated variables and compare it with the intended data-generating settings. Track p-values, model failures, missingness, and rejection counts by scenario. Unexpected patterns may point to a coding error, an analysis assumption that is not met, or a scenario that exposes sensitivity to nuisance parameters.

If the decision rule appears miscalibrated, first identify the cause. A different analysis may be more appropriate under the simulated conditions; alternatively, the decision threshold may need adjustment. Threshold selection should use the actual overall decision rule and the scenarios relevant to the error-control claim. Avoid repeatedly changing a threshold in response to noisy simulation estimates and then reporting the same runs as validation. Once a rule is selected, evaluate it using fresh independent simulation replicates and report both the estimated rates and their Monte Carlo uncertainty.

Simulation is especially useful when the complete design and analysis are too complex for a simple analytic calculation. Where a standard test has a trustworthy exact or asymptotic result under assumptions that hold, that result can provide a useful benchmark. Direct null simulation can assess the whole planned pipeline, but it depends on the data-generating assumptions and the scenarios chosen. It does not prove control for unexamined settings, and a small Monte Carlo standard error does not address uncertainty about whether the scenarios represent the trial.